Split History
How to Retire on 8%+ Dividends Paid Monthly »    NVGN Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Novogen is a global oncology biotechnology company, focused on developing cancer treatments. Co. has two main drug technology platforms: super-benzopyran and anti-tropomyosins (ATM). Within those platforms, Co. has three drug candidates under development: Cantrixil (TRX-E-002-1), for women with later-stage ovarian cancer; Anisina (ATM-3507), which is designed to enhance chemotherapy agents such as taxanes and vinca alkaloids, which are used across a range of cancer treatments including lung, prostate, colon, gastric, prostrate, pancreatic and breast cancer, as well as many childhood cancers; and Trilexium (TRX-E-009-1), for treatment of renal cancer and several childhood cancers. According to our NVGN split history records, NVGN has had 2 splits.
NVGN split history picture
NVGN (NVGN) has 2 splits in our NVGN split history database. The first split for NVGN took place on January 28, 2013. This was a 3038 for 1000 split, meaning for each 1000 shares of NVGN owned pre-split, the shareholder now owned 3038 shares. For example, a 1000 share position pre-split, became a 3038 share position following the split. NVGN's second split took place on January 03, 2012. This was a 1 for 5 reverse split, meaning for each 5 shares of NVGN owned pre-split, the shareholder now owned 1 share. For example, a 3038 share position pre-split, became a 607.6 share position following the split.

When a company such as NVGN splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as NVGN conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the NVGN split history from start to finish, an original position size of 1000 shares would have turned into 607.6 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into NVGN shares, starting with a $10,000 purchase of NVGN, presented on a split-history-adjusted basis factoring in the complete NVGN split history. NVGN split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/07/2011
End date: 11/22/2017
Start price/share: $1.20
End price/share: $3.17
Dividends collected/share: $0.00
Total return: 164.17%
Average Annual Total Return: 15.56%
Starting investment: $10,000.00
Ending investment: $26,419.77
Years: 6.72
Date Ratio
01/28/20133038 for 1000
01/03/20121 for 5
NVGN is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

NVIV Split History
NVLS Split History
NVO Split History
NVUS Split History
NWBO Split History
OBLN Split History
OCLS Split History
OCR Split History
OCRX Split History
OGEN Split History

Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
MicroSectors FANG+ Index 2X Leveraged ETNs due January 8, 2038 (FNGO)
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038 (FNGU)
Moleculin Biotech, Inc. (MBRX)
Exela Technologies, Inc. (XELA)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

NVGN Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.